Werner Weitschies
Department of Biopharmaceutics and Pharmaceutical Technology
University of Greifswald
D-17487 Greifswald
Germany
Name/email consistency: high
- Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract. Weitschies, W., Blume, H., Mönnikes, H. Eur. J. Pharm. Biopharm (2010)
- Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying. Weitschies, W., Friedrich, C., Wedemeyer, R.S., Schmidtmann, M., Kosch, O., Kinzig, M., Trahms, L., Sörgel, F., Siegmund, W., Horkovics-Kovats, S., Schwarz, F., Raneburger, J., Mönnikes, H. Eur. J. Pharm. Biopharm (2008)
- The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen. Weitschies, W., Bernsdorf, A., Giessmann, T., Zschiesche, M., Modess, C., Hartmann, V., Mrazek, C., Wegner, D., Nagel, S., Siegmund, W. Pharm. Res. (2005)
- Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Weitschies, W., Kosch, O., Mönnikes, H., Trahms, L. Adv. Drug Deliv. Rev. (2005)
- Impact of the intragastric location of extended release tablets on food interactions. Weitschies, W., Wedemeyer, R.S., Kosch, O., Fach, K., Nagel, S., Söderlind, E., Trahms, L., Abrahamsson, B., Mönnikes, H. J. Control. Release (2005)
- Magnetic marker monitoring of disintegrating capsules. Weitschies, W., Karaus, M., Cordini, D., Trahms, L., Breitkreutz, J., Semmler, W. Eur. J. Pharm. Sci (2001)
- Determination of the disintegration behavior of magnetically marked tablets. Weitschies, W., Hartmann, V., Grützmann, R., Breitkreutz, J. Eur. J. Pharm. Biopharm (2001)